Delix Therapeutics Expands Executive Leadership Team

BOSTON, July 6, 2021 /PRNewswire/ — Preclinical neuroscience company Delix Therapeutics (the “Company”), today announced the growth of its executive leadership team with two new leadership appointments. Internationally recognized neuroscientist Dr. Kurt Rasmussen will join the company as…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.